These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2563001)

  • 1. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.
    Palmer A; Taube D; Welsh K; Bewick M; Gjorstrup P; Thick M
    Lancet; 1989 Jan; 1(8628):10-2. PubMed ID: 2563001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates.
    Rostaing L; Congy N; Aarnink A; Maggioni S; Allal A; Sallusto F; Game X; Kamar N
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():201-6. PubMed ID: 25894155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal immunoadsorption of anti-HLA antibodies: preliminary clinical experience.
    Palmer A; Taube D; Welsh K; Brynger H; Delin K; Gjörstrup P; Konar J; Söderström T
    Transplant Proc; 1987 Oct; 19(5):3750-1. PubMed ID: 3313909
    [No Abstract]   [Full Text] [Related]  

  • 5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HLA antibody removal by extracorporeal immunoadsorption in two hyperimmunized pediatric patients awaiting hepatointestinal transplantation.
    Tschernia A; LeLeiko NS; Grima K; Whittset C; Molnar K; Spencer RW; Sloves MF; Gondolesi G; Kaufman SS; Fishbein TM
    Transplant Proc; 2002 May; 34(3):900-1. PubMed ID: 12034228
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients.
    Bevan DJ; Carey BS; Vaughan RW; Fallon M; Higgins RM; Hendry BM; Bewick M
    Transplant Proc; 1997; 29(1-2):1448. PubMed ID: 9123375
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of donor-specific antibodies in renal transplantation.
    Tozkir H; Sağiroğlu T; Kiliçarslan-Ayna T; Tan S; Çopuroğlu E; Sağiroğlu G; Sari G; Gürkan H; Sezer A
    Transplant Proc; 2012; 44(6):1667-9. PubMed ID: 22841240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplantation immunoadsorption therapy in patients immunized with human lymphocyte antigen: effect of treatment and three years' clinical follow-up of grafts.
    Alarabi AA; Wikström B; Backman U; Danielson BG; Tufvesson G; Sjöberg O
    Artif Organs; 1993 Aug; 17(8):702-7. PubMed ID: 8215951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
    Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
    Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoadsorption of anti-B antibodies as preparation for an ABO-incompatible kidney transplantation].
    Aeschbacher B; Wiedmer W; Stuck A; Gaenger KH; Frey FJ; Nydegger UE
    Schweiz Med Wochenschr; 1987 May; 117(19):716-22. PubMed ID: 3296166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients.
    Kupin WL; Venkat KK; Hayashi H; Mozes MF; Oh HK; Watt R
    Transplantation; 1991 Feb; 51(2):324-9. PubMed ID: 1994523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption of anti-HLA antibodies for highly sensitized patients awaiting renal transplantation.
    Hiesse C; Kriaa F; Rousseau P; Farahmand H; Bismuth A; Fries D; Charpentier B
    Nephrol Dial Transplant; 1992; 7(9):944-51. PubMed ID: 1328943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience.
    Mastrangelo F; Pretagostini R; Berloco P; Poli L; Cinti P; Patruno P; Alfonso L; Pompei L; Carboni F; Rizzelli S
    Transplant Proc; 1995 Feb; 27(1):892-5. PubMed ID: 7879221
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoadsorption in acute vascular rejection after renal transplantation.
    Persson NH; Bucin D; Ekberg H; Källén R; Omnell Persson M; Simanaitis M; Sterner G; Swedenborg P
    Transplant Proc; 1995 Dec; 27(6):3466. PubMed ID: 8540054
    [No Abstract]   [Full Text] [Related]  

  • 19. [Induction treatment by combining immunoglobulins, plasmapheresis and rituximab in hypersensitive patients receiving cadaveric renal allograft].
    Rufino Hernández JM; Cabello Moya E; González-Posada JM; Hernández Marrero D; Pérez Tamajón L; Marrero Miranda D; García Rebollo S; Martín Urcuyo B; Rodríguez Hernández A; Franco Maside A; Barrios del Pino Y; Rodríguez Rodríguez R; Maceira Cruz B; Torres Ramírez A; Salido Ruiz E
    Nefrologia; 2010; 30(2):252-7. PubMed ID: 20098463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal removal of anti-HLA antibodies in transplant candidates.
    Hakim RM; Milford E; Himmelfarb J; Wingard R; Lazarus JM; Watt RM
    Am J Kidney Dis; 1990 Nov; 16(5):423-31. PubMed ID: 2239932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.